GSTM3 Function and Polymorphism in Cancer: Emerging but Promising.

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Cancer remains a leading cause of mortality, with incomplete understanding of its molecular drivers.
• Glutathione S-transferases mu3 (GSTM3) is a phase II enzyme involved in detoxifying xenobiotics and metabolizing electrophilic substances.
• GSTM3 exhibits polymorphisms and influences tumorigenesis, invasion, metastasis, chemoresistance, and oxidative stress in various cancers.

Purpose of the Study:

• To provide a comprehensive overview of GSTM3.
• To elucidate the role of GSTM3 in cancer development and progression.
• To highlight the potential of GSTM3 as a biomarker and therapeutic target.

Main Methods:

• Literature review and synthesis of existing research on GSTM3.
• Analysis of GSTM3's involvement in carcinogen metabolism and detoxification pathways.
• Examination of GSTM3's regulatory functions in cellular processes relevant to cancer.

Main Results:

• GSTM3 polymorphisms are linked to differential cancer susceptibility and progression.
• GSTM3 modulates key cancer hallmarks including invasion, metastasis, and chemoresistance.
• GSTM3 is implicated in regulating reactive oxygen species (ROS) and oxidative stress-mediated pathology.

Conclusions:

• GSTM3 is a significant factor in cancer biology, affecting multiple aspects of tumor progression.
• Further research into GSTM3 regulatory mechanisms and functions can advance cancer prevention strategies.
• Targeting GSTM3 or understanding its interactions may offer novel avenues for cancer therapy.